Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Is your feature request related to a problem or challenge? We use protobuf to serialize and deserialize frequently in the FFI work. This has been a great advantage in exposing these functions and ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

A superb fairy-wren calls to a Horsfield's bronze-cuckoo. Brood parasites like cuckoos lay eggs in other birds' nests and leave them behind for the host birds to raise. David Ongley / Cornell Lab of ...

U.S. officials told ABC News they don’t know what the meeting is about. Defense Secretary Pete Hegseth has ordered a large number of general officers and admirals to gather next Tuesday at the Marine ...

Functions are the building blocks of Python programs. They let you write reusable code, reduce duplication, and make projects easier to maintain. In this guide, we’ll walk through all the ways you can ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...

A growing number of IT leaders believe the solution to declining productivity and rising digital complexity in the workplace could lie in merging HR and IT departments, according to a new poll. A ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...